TAK logo

TAK Cash From Financing

Annual CFF

-$2.46 B
+$2.80 B+53.23%

March 31, 2024

Summary

Performance

1-Year Change

+53.23%

3-Year Change

+76.08%

5-Year Change

-109.24%

15-Year Change

-191.62%

TAK Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.22%
TAK annual cash flow from financing activities is higher than 1.22% of companies in Healthcare sector

High & Low

All-time High

$26.58 B
TAK annual cash flow from financing activities is currently -109.24% below its historical high of $26.58 billion

3-Year Low

-$10.27 B

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
TAK previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

May 9, 2025
TAK next annual earnings announcement is scheduled for May 9, 2025

OtherTAKcash flowmetrics:

Annual CFI

-$3.21 B
TAK annual cash flow from investing activities is -$3.21 billion

Annual CFO

$4.96 B
TAK annual cash flow from operations is $4.96 billion

Annual FCF

$1.63 B
TAK annual free cash flow is $1.63 billion

Annual CAPEX

$3.33 B
TAK annual capital expenditures is $3.33 billion

Quarterly CFF

-$4.34 B
-$3.70 B-577.25%

December 1, 2024

Summary

Performance

3-Month Change

-577.25%

1-Year Change

-577.25%

3-Year Change

-1515.98%

5-Year Change

-27.96%

TAK Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.18%
TAK quarterly cash flow from financing activities is higher than 0.18% of companies in Healthcare sector

High & Low

All-time High

$14.05 B
TAK quarterly cash flow from financing activities is currently -130.87% below its historical high of $14.05 billion

3-Year Low

-$4.34 B
TAK quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
TAK previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
TAK next earnings announcement is scheduled for May 9, 2025

OtherTAKcash flowmetrics:

Quarterly CFI

-$716.72 M
TAK quarterly cash flow from investing activities is -$716.72 million

Quarterly CFO

$2.44 B
TAK quarterly cash flow from operations is $2.44 billion

Quarterly FCF

$2.11 B
TAK quarterly free cash flow is $2.11 billion

Quarterly CAPEX

$330.81 M
TAK quarterly capital expenditures is $330.81 million

TTM CFF

-$3.40 B
-$3.70 B-1207.42%

December 1, 2024

Summary

Performance

3-Month Change

-1207.42%

1-Year Change

-1207.42%

3-Year Change

+35.3%

5-Year Change

+66.9%

TAK TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.31%
TAK TTM cash flow from financing activities is higher than 1.31% of companies in Healthcare sector

High & Low

All-time High

$26.58 B
TAK TTM cash flow from financing activities is currently -112.79% below its historical high of $26.58 billion

3-Year Low

-$10.66 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
TAK previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
TAK next earnings announcement is scheduled for May 9, 2025

OtherTAKcash flowmetrics:

TTM CFI

-$2.77 B
TAK TTM cash flow from investing activities is -$2.77 billion

TTM CFO

$7.47 B
TAK TTM cash flow from operations is $7.47 billion

TTM FCF

$5.08 B
TAK TTM free cash flow is $5.08 billion

TTM CAPEX

$2.39 B
TAK TTM capital expenditures is $2.39 billion

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TAK Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+53.2%-577.3%-1207.4%
3 y3 years+76.1%-1516.0%+35.3%
5 y5 years-109.2%-28.0%+66.9%

TAK Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+76.1%-313.7%at low-1207.4%+68.1%
5 y5-year-109.2%+76.1%-313.7%at low-155.4%+72.4%
alltimeall time-109.2%+76.1%-130.9%+27.1%-112.8%+72.4%

Takeda Pharmaceutical Company Limited Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
-
-$4.34 B(+577.3%)
-$3.40 B(-1207.4%)
Sep 2024
-
-$640.38 M(-131.6%)
$306.83 M(-5700.9%)
Jun 2024
-
$2.03 B(-550.9%)
-$5.48 M(-99.8%)
Mar 2024
-$2.46 B(-53.2%)
-$450.06 M(-28.8%)
-$2.46 B(+8.0%)
Dec 2023
-
-$632.25 M(-33.6%)
-$2.27 B(-51.5%)
Sep 2023
-
-$952.69 M(+126.3%)
-$4.69 B(+17.0%)
Jun 2023
-
-$421.06 M(+56.9%)
-$4.01 B(-23.7%)
Mar 2023
-$5.25 B(-44.9%)
-$268.38 M(-91.2%)
-$5.25 B(-27.5%)
Dec 2022
-
-$3.05 B(+1018.9%)
-$7.25 B(+32.0%)
Sep 2022
-
-$272.26 M(-83.6%)
-$5.49 B(-26.3%)
Jun 2022
-
-$1.66 B(-26.4%)
-$7.44 B(-21.9%)
Mar 2022
-$9.53 B(-7.1%)
-$2.26 B(+75.7%)
-$9.53 B(-10.6%)
Dec 2021
-
-$1.29 B(-42.1%)
-$10.66 B(-13.4%)
Sep 2021
-
-$2.23 B(-40.7%)
-$12.31 B(+0.6%)
Jun 2021
-
-$3.76 B(+10.8%)
-$12.23 B(+19.1%)
Mar 2021
-$10.27 B(+11.0%)
-$3.39 B(+15.4%)
-$10.27 B(+25.1%)
Dec 2020
-
-$2.94 B(+36.6%)
-$8.21 B(+46.0%)
Sep 2020
-
-$2.15 B(+20.0%)
-$5.62 B(-40.3%)
Jun 2020
-
-$1.79 B(+34.9%)
-$9.42 B(+1.9%)
Mar 2020
-$9.25 B(-134.8%)
-$1.33 B(+275.8%)
-$9.25 B(-250.9%)
Dec 2019
-
-$353.41 M(-94.1%)
$6.13 B(-69.2%)
Sep 2019
-
-$5.95 B(+268.0%)
$19.88 B(-22.7%)
Jun 2019
-
-$1.62 B(-111.5%)
$25.71 B(-3.2%)
Mar 2019
$26.58 B(-1002.6%)
$14.05 B(+4.9%)
$26.58 B(+138.5%)
Dec 2018
-
$13.40 B(<-9900.0%)
$11.14 B(-492.1%)
Sep 2018
-
-$118.49 M(-84.3%)
-$2.84 B(-2.3%)
Jun 2018
-
-$753.32 M(-45.6%)
-$2.91 B(-1.3%)
Mar 2018
-$2.94 B(-209.8%)
-$1.38 B(+136.2%)
-$2.94 B(-453.9%)
Dec 2017
-
-$585.80 M(+217.7%)
$831.87 M(+11.3%)
Sep 2017
-
-$184.37 M(-76.7%)
$747.52 M(-12.0%)
Jun 2017
-
-$790.50 M(-133.0%)
$849.16 M(-68.3%)
Mar 2017
$2.68 B
$2.39 B(-457.0%)
$2.68 B(+355.5%)
Dec 2016
-
-$670.16 M(+710.0%)
$588.57 M(-18.5%)
DateAnnualQuarterlyTTM
Sep 2016
-
-$82.73 M(-107.9%)
$722.47 M(+1.1%)
Jun 2016
-
$1.04 B(+246.5%)
$714.37 M(-168.7%)
Mar 2016
-$1.04 B(-62.2%)
$300.42 M(-156.0%)
-$1.04 B(-60.2%)
Dec 2015
-
-$536.25 M(+490.3%)
-$2.61 B(+3.1%)
Sep 2015
-
-$90.84 M(-87.3%)
-$2.54 B(-5.7%)
Jun 2015
-
-$713.66 M(-43.9%)
-$2.69 B(-2.3%)
Mar 2015
-$2.75 B(-385.7%)
-$1.27 B(+177.8%)
-$2.75 B(+71.5%)
Dec 2014
-
-$458.27 M(+87.0%)
-$1.60 B(-11.3%)
Sep 2014
-
-$245.10 M(-68.4%)
-$1.81 B(-316.6%)
Jun 2014
-
-$775.89 M(+519.5%)
$834.97 M(-13.3%)
Mar 2014
$963.50 M(-152.3%)
-$125.25 M(-81.1%)
$963.50 M(-11.5%)
Dec 2013
-
-$662.29 M(-127.6%)
$1.09 B(-37.8%)
Sep 2013
-
$2.40 B(-470.5%)
$1.75 B(-370.5%)
Jun 2013
-
-$647.36 M(+1354.6%)
-$647.36 M(-62.0%)
Mar 2013
-$1.84 B(-136.9%)
-
-
Mar 2012
$4.99 B(-393.1%)
-
-
Mar 2011
-$1.70 B(+6.7%)
-$44.50 M(-94.5%)
-$1.70 B(-1.6%)
Dec 2010
-
-$807.49 M(+412.8%)
-$1.73 B(+4.6%)
Sep 2010
-
-$157.47 M(-77.3%)
-$1.65 B(+2.2%)
Jun 2010
-
-$692.50 M(+868.4%)
-$1.62 B(+1.4%)
Mar 2010
-$1.60 B(-62.7%)
-$71.51 M(-90.2%)
-$1.60 B(+4.7%)
Dec 2009
-
-$731.82 M(+497.4%)
-$1.52 B(+92.4%)
Sep 2009
-
-$122.50 M(-81.7%)
-$792.25 M(+18.3%)
Jun 2009
-
-$669.75 M
-$669.75 M
Mar 2009
-$4.28 B(+86.2%)
-
-
Mar 2008
-$2.30 B(-14.9%)
-
-
Mar 2007
-$2.70 B(+242.2%)
-
-
Mar 2006
-$789.71 M(+14.7%)
-
-
Mar 2005
-$688.75 M(+30.8%)
-
-
Mar 2004
-$526.51 M(+8.6%)
-
-
Mar 2003
-$484.60 M(+14.9%)
-
-
Mar 2002
-$421.79 M(+11.1%)
-
-
Mar 2001
-$379.79 M(+50.9%)
-
-
Mar 2000
-$251.64 M
-
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual CFF year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly CFF year-on-year change?
  • What is Takeda Pharmaceutical Company Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited TTM CFF year-on-year change?

What is Takeda Pharmaceutical Company Limited annual cash flow from financing activities?

The current annual CFF of TAK is -$2.46 B

What is the all time high annual CFF for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual cash flow from financing activities is $26.58 B

What is Takeda Pharmaceutical Company Limited annual CFF year-on-year change?

Over the past year, TAK annual cash flow from financing activities has changed by +$2.80 B (+53.23%)

What is Takeda Pharmaceutical Company Limited quarterly cash flow from financing activities?

The current quarterly CFF of TAK is -$4.34 B

What is the all time high quarterly CFF for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly cash flow from financing activities is $14.05 B

What is Takeda Pharmaceutical Company Limited quarterly CFF year-on-year change?

Over the past year, TAK quarterly cash flow from financing activities has changed by -$3.70 B (-577.25%)

What is Takeda Pharmaceutical Company Limited TTM cash flow from financing activities?

The current TTM CFF of TAK is -$3.40 B

What is the all time high TTM CFF for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high TTM cash flow from financing activities is $26.58 B

What is Takeda Pharmaceutical Company Limited TTM CFF year-on-year change?

Over the past year, TAK TTM cash flow from financing activities has changed by -$3.70 B (-1207.42%)